1. Home
  2. Infos und Fachliteratur
  3. Photodynamische Therapie
  4. Fachliteratur

Photodynamische Therapie - Fachliteratur

  1. Ablon G. Phototherapy with Light Emitting Diodes: Treating a Broad Range of Medical and Aesthetic Conditions in Dermatology. J Clin Aesthet Dermatol. 2018 Feb;11(2):21-27. [PDF]

  2. Abrahamse H, Hamblin MR. New photosensitizers for photodynamic therapy. Biochem J. Author manuscript; available in PMC 2017 Feb 15. Published in final edited form as: Biochem J. 2016 Feb 15; 473(4): 347–364.

  3. Adili F und Schmitz-Rixen TH. Vaskuläre photodynamische Therapie: Eine innovative Strategie zur Prävention von postinterventionellen Restenosen. Vasa 2004; 33: 59-64.

  4. Agostinis P, Berg K, Cengel Keith A, Foster Thomas H, Girotti Albert W, Gollnick Sandra O, Hahn Stephen M, Hamblin Michael R, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson Brian C, Golab J. Photodynamic Therapy of Cancer: an Update. CA Cancer J Clin. 2011 ; 61(4): 250–281. doi:10.3322/caac.20114.

  5. Akimoto J, Haraoka J, Aizawa K. Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. Photodiagnosis Photodyn Ther. 2012 Jun;9(2):91-9.

  6. Al-Ahmad A, Walankiewicz A, Hellwig E, Follo M, Tennert C, Wittmer A, Karygianni L. Photoinactivation Using Visible Light Plus Water-Filtered Infrared-A (vis+wIRA) and Chlorine e6 (Ce6) Eradicates Planktonic Periodontal Pathogens and Subgingival Biofilms. Front Microbiol. 2016 Nov 28;7:1900 [PDF]

  7. Al-Ahmad A, Bucher M, Anderson AC, Tennert C, Hellwig E, Wittmer A, Vach K, Karygianni L. Antimicrobial Photoinactivation Using Visible Light Plus Water-Filtered Infrared-A (VIS + wIRA) Alters In Situ Oral Biofilms. PLoS One. 2015 Jul 10;10(7):e0132107. [PDF]

  8. Al-Ahmad A, Tennert C, Karygianni L, Wrbas KT, Hellwig E, Altenburger MJ. Antimicrobial photodynamic therapy using visible light plus water-filtered infrared-A (wIRA). J Med Microbiol. 2013 Mar;62(Pt 3):467-73.

  9. Alphandéry E, Idbaih A, Adam C, Delattre JY, Schmitt C, Guyot F, Chebbi I. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia. Biomaterials. 2017 Oct;141:210-222.

  10. Alster TS, Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol 2003; 2: 501–504.

  11. Alves F, Alonso GC, Carmello JC, Mima EGO, Bagnato VS, Pavarina AC. Antimicrobial Photodynamic Therapy mediated by Photodithazine® in the treatment of denture stomatitis: A case report. Photodiagnosis Photodyn Ther. 2018 Mar;21:168-171.

  12. Arits AH, Mosterd K, Essers BA, Spoorenberg E, Sommer A, De Rooij MJ, van Pelt HP, Quaedvlieg PJ, Krekels GA, van Neer PA, Rijzewijk JJ, van Geest AJ, Steijlen PM, Nelemans PJ, Kelleners-Smeets NW. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 2013 Jun;14(7):647-54.

  13. Arnold JJ, Blinder KJ, Bressler NM, Bressler SB, Burdan A, Haynes L, Lim JI, Miller JW, Potter MJ, Reaves A, Rosenfeld PJ, Sickenberg M, Slakter JS, Soubrane G, Strong HA, Stur M; Treatment of Age-Related Macular Degeneration with (Photodynamic Therapy Study Group). Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3. Am J Ophthalmol. 2004 Apr;137(4):683-96.

  14. Azab M, Boyer DS, Bressler NM, Bressler SB, Cihelkova I, Hao Y, Immonen I, Lim JI, Menchini U, Naor J, Potter MJ, Reaves A, Rosenfeld PJ, Slakter JS, Soucek P, Strong HA, Wenkstern A, Su XY, Yang YC; Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial. Arch Ophthalmol. 2005 Apr;123(4):448-57.

  15. Aziz F, Telara S, Moseley H, Goodman C, Manthri P, Eljamel MS. Photodynamic therapy adjuvant to surgery in metastatic carcinoma in brain. Photodiagnosis Photodyn Ther. 2009 Sep-Dec;6(3-4):227-30.

  16. Babilas P, Kohl E, Maisch T, Bäcker H, Gross B, Branzan AL, Bäumler W, Landthaler M, Karrer S, Szeimies RM. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol. 2006 Apr;154(4):712-8.

  17. Ballester AR, Lafuente MT. LED blue light-induced changes in phenolics and ethylene in citrus fruit: implication in elicited resistance against Penicillium digitatum infection. Food Chem. 2017;218:575–583.

  18. Bargrizan M, Fekrazad R, Goudarzi N, Goudarzi N. Effects of antibacterial photodynamic therapy on salivary mutans streptococci in 5- to 6-year-olds with severe early childhood caries. Lasers Med Sci. 2018 Oct 11. doi: 10.1007/s10103-018-2650-2. [Epub ahead of print]

  19. Barolet D, Boucher A. Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome. Lasers Surg Med. 2010 Feb;42(2):171-8.

  20. Baskaran R, Lee J, Yang SG. Clinical development of photodynamic agents and therapeutic applications. Biomater Res. 2018 Sep 26;22:25. [PDF]

  21. Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M, Calzavara-Pinton P, Varma S, Roelandts R, Wolf P. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol. 2008 Sep-Oct;18(5):547-53.

  22. Boixadera A, García-Arumí J, Martínez-Castillo V, Encinas JL, Elizalde J, Blanco-Mateos G, Caminal J, Capeans C, Armada F, Navea A, Olea JL. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology. 2009 Jan;116(1):100-105.

  23. Borgia F, Vaccaro M, Giuffrida R, Cannavò SP. Photodynamic therapy for acne conglobata of the buttocks: Effective antiinflammatory treatment with good cosmetic outcome. Indian J Dermatol Venereol Leprol 2018;84:617-9

  24. Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol. 2001 Feb;119(2):198-207.

  25. Cadore UB, Reis MBL, Martins SHL, Invernici MM, Novaes AB Jr, Taba M Jr, Palioto DB, Messora MR, Souza SLS. Multiple sessions of antimicrobial photodynamic therapy associated with surgical periodontal treatment in patients with chronic periodontitis. J Periodontol. 2018 Nov 1. doi: 10.1002/JPER.18-0373. [Epub ahead of print]

  26. Calzavara-Pinton PG, Rossi MT, Aronson E, Sala R, Italian Group for Photodynamic Therapy A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. 1. Inflammatory and aesthetic indications. Photochem Photobiol Sci. 2013;12:148–157.

  27. Canti GL, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Immunopharmacology studies on photosensitizers used in photodynamic therapy. Proc SPIE. 1994; 2078:268–275.

  28. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther. 2004 Dec;1(4):279-93. [PDF]

  29. Castaño-Suárez E, Romero-Maté A, Arias-Palomo D, Borbujo J. Photodynamic therapy for the treatment of folliculitis decalvans. Photodermatol Photoimmunol Photomed. 2012 Apr;28(2):102-4.

  30. Chan WM, Lai TY, Lai RY, Tang EW, Liu DT, Lam DS. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. Retina. 2008 Jan;28(1):85-93.

  31. Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Phototherapy in the treatment of acne vulgaris: what is its role? Am J Clin Dermatol. 2004;5(4):211-6.

  32. Chen X, Song H, Chen S, Zhang J, Niu G, Liu X. Clinical efficacy of 5-aminolevulinic acid photodynamic therapy in the treatment of moderate to severe facial acne vulgaris. Exp Ther Med. 2015 Sep;10(3):1194-1198. [PDF]

  33. Chrepa V, Kotsakis GA, Pagonis TC, Hargreaves KM. The effect of photodynamic therapy in root canal disinfection: a systematic review. J Endod. 2014 Jul;40(7):891-8.

  34. Cieplik F, Deng D, Crielaard W, Buchalla W, Hellwig E, Al-Ahmad A, Maisch T. Antimicrobial photodynamic therapy - what we know and what we don't. Crit Rev Microbiol. 2018 Sep;44(5):571-589.

  35. Cieplik F, Buchalla W, Hellwig E, Al-Ahmad A, Hiller KA, Maisch T, Karygianni L. Antimicrobial photodynamic therapy as an adjunct for treatment of deep carious lesions-A systematic review. Photodiagnosis Photodyn Ther. 2017 Jun;18:54-62.

  36. Collier NJ, Allan D, Diaz Pesantes F, Sheridan L, Allan E. Systemic photodynamic therapy in folliculitis decalvans. Clin Exp Dermatol. 2018 Jan;43(1):46-49.

  37. Cuenca RE, Allison RR, Sibata C, Downie GH. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol. 2004 Mar;11(3):322-7.

  38. da Collina GA, Freire F, Santos TPDC, Sobrinho NG, Aquino S, Prates RA, da Silva DFT, Tempestini Horliana ACR, Pavani C. Controlling methylene blue aggregation: a more efficient alternative to treat Candida albicans infections using photodynamic therapy. Photochem Photobiol Sci. 2018 Oct 10;17(10):1355-1364

  39. Dai T. The antimicrobial effect of blue light: what are behind? Virulence. 2017;8(6):649–652.

  40. Damke GMZF, Souza RP, Montanha MC, Damke E, Gonçalves RS, Cesar GB, Kimura E, Caetano W, Hioka N, Consolaro MEL. Selective photodynamic effects on breast cancer cells provided by P123 Pluronic®-based nanoparticles modulating hypericin delivery. Anticancer Agents Med Chem. 2018 Nov 1. doi: 10.2174/1871520618666181102091010. [Epub ahead of print]

  41. de Leeuw J, van der Beek N, Bjerring P, Neumann HA. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents. J Eur Acad Dermatol Venereol. 2010 Apr;24(4):460-9.

  42. de Leeuw J, de Vijlder HC, Bjerring P, Neumann HA. Liposomes in dermatology today. J Eur Acad Dermatol Venereol. 2009 May;23(5):505-16.

  43. de Miranda RG, Colombo APV. Clinical and microbiological effectiveness of photodynamic therapy on primary endodontic infections: a 6-month randomized clinical trial. Clin Oral Investig. 2018 May;22(4):1751-1761.

  44. De Rosa FS, Bentley MV. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm Res. 2000; 17:1447–1455

  45. Ding C, Ma YY, Wang P, Liu J. Multiple Bowen's diseases and basal cell carcinomas in a patient with acute promyelocytic leukemia treated with arsenic trioxide: A case report and effective treatment with photodynamic therapy. Dermatol Ther. 2018 Sep 21:e12718.

  46. Dos Santos AF, Terra LF, Wailemann RA, Oliveira TC, Gomes VM, Mineiro MF, Meotti FC, Bruni-Cardoso A, Baptista MS, Labriola L. Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells. BMC Cancer. 2017 Mar 15;17(1):194.

  47. Dovigo LN, Pavarina AC, Carmello JC, Machado AL, Brunetti IL, Bagnato VS. Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin. Lasers Surg Med. 2011 Nov;43(9):927-34.

  48. Drucker A, Adam GP, Langberg V, Gazula A, Smith B, Moustafa F, Weinstock MA, Trikalinos TA. Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Dec. [PDF]

  49. Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina. 2007 Sep;27(7):825-31.

  50. Eljamel MS. PDT for brain cancer. In: Advances in photodynamic therapy: basic, translational and clinical. Eds. MR Hamblin und P Mroz. 2008. Kapitel 26, 495-507

  51. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci. 2008 Oct;23(4):361-7.

  52. Eljamel MS. Photodynamic applications in brain tumors: a comprehensive review of the literature. Photodiagnosis Photodyn Ther. 2010 Jun;7(2):76-85

  53. Ericson MB, Wennberg AM, Larkö O. Review of photodynamic therapy in actinic keratosis and basal cell carcinoma. Ther Clin Risk Manag. 2008;4:1–9. [PDF]

  54. Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros AM, Rosén A, Larkö O, Wennberg AM, Rosdahl I. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of  photobleaching, pain and primary clinical outcome. Br J Dermatol 2004; 151:1204–12.

  55. Fathy G, Asaad MK, Rasheed HM. Daylight photodynamic therapy with methylene blue in plane warts: a randomized double-blind placebo-controlled study. Photodermatol Photoimmunol Photomed. 2017 Jul;33(4):185-192.

  56. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai KE, Murrell D, Weightman W, Anderson C, Reid C, Watson A, Foley P. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat. 2003 Jun;14(2):99-106.

  57. Garcez AS, Nuñez SC, Hamblim MR, Suzuki H, Ribeiro MS. Photodynamic therapy associated with conventional endodontic treatment in patients with antibiotic-resistant microflora: a preliminary report. J Endod. 2010 Sep;36(9):1463-6.

  58. Gold MH. Therapeutic and aesthetic uses of photodynamic therapy part five of a five-part series: ALA-PDT and MAL-PDT what makes them different. J Clin Aesthet Dermatol 2009; 2: 44–47.

  59. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Lewis TL: Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol 2004; 3: 6–9.

  60. Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res. 2002; 62:1604–1608.

  61. Gomer CJ, Ferrario A, Murphree AL. The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. Br J Cancer. 1987; 56:27–32.

  62. Griffin LL, Lear JT. Photodynamic Therapy and Non-Melanoma Skin Cancer. Cancers (Basel). 2016 Oct 22;8(10).  [PDF]

  63. Grimm WD. Effektivitätsvergleich von zwei Therapiemodifikationen mit einem BluLase Dioden-Laser und Photodynamischer Therapie (PDT) sowie einem BluLase Dioden-Laser bei der nicht chirurgischen Parodontaltherapie -eine mikrobiologische Studie. Forschungsbericht der Molthera GmbH, 2012; 1-89. [PDF]

  64. Hamblin MR. Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes Curr Opin Microbiol. Author manuscript; available in PMC 2017 Oct 1. Published in final edited form as: Curr Opin Microbiol. 2016 Oct; 33: 67–73. [PDF]

  65. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–192

  66. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–192

  67. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol. 2000;136:1093–1095.

  68. Jung YR, Kim SJ, Sohn KC, Lee Y, Seo YJ, Lee YH, Whang KU, Kim CD, Lee JH, Im M. Regulation of lipid production by light-emitting diodes in human sebocytes. Arch Dermatol Res. 2015 Apr;307(3):265-73.

  69. Jutley G, Jutley G, Tah V, Lindfield D, Menon G. Treating peripapillary choroidal neovascular membranes: a review of the evidence. Eye (Lond). 2011 Jun;25(6):675-81. [PDF]

  70. Kabingu E, Vaughan L, Owczarczak B, Ramsey KD, Gollnick SO. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer. 2007; 96:1839–1848.

  71. Kaneko S und Kondo M. Photodynamic medicine in malignant glioma-the reason why ALA induced PpIX is accumulated. In: Proceedings of the 7th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, Oct 7-11, 2008, Brixen/Bressanone, Italy.

  72. Kaneko S. Photodynamic therapy for human malignant glioma. Nippon Laser Igakkaishi. 2011;32(2):131–138.

  73. Kaneko S, Fujimoto S, Yamaguchi H, Yamauchi T, Yoshimoto T, Tokuda K. Photodynamic Therapy of Malignant Gliomas. Prog Neurol Surg. 2018;32:1-13.

  74. Karygianni L, Ruf S, Follo M, Hellwig E, Bucher M, Anderson AC, Vach K, Al-Ahmad A. Novel Broad-Spectrum Antimicrobial Photoinactivation of In Situ Oral Biofilms by Visible Light plus Water-Filtered Infrared A. Appl Environ Microbiol. 2014 Dec;80(23):7324-36.

  75. Kim SK, Do JE, Kang HY, Lee ES, Kim YC. Combination of topical 5-aminolevulinic acid-photodynamic therapy with carbon dioxide laser for sebaceous hyperplasia. J Am Acad Dermatol 2007; 56: 523–524.

  76. Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina. 2012 Sep;32(8):1453-64.

  77. Korbelik M, Merchant S, Huang N. Exploitation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors. Photochem Photobiol. 2009; 85:1418–1424.

  78. Korbelik M. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med. 2006a; 38:500–508.

  79. Korbelik M, Sun J. Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol Immunother. 2006b; 55:900–909.

  80. Korbelik M, Dougherty GJ. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. Cancer Res. 1999; 59:1941–1946.

  81. Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop K, Kotlińska J, Michel O, Kotowski K, Kulbacka J. Photodynamic therapy – mechanisms, photosensitizers and combinations. Biomedicine & Pharmacotherapy. 2018; 106:1098–1107. [PDF]

  82. Lacour JP, Ulrich C, Gilaberte Y, Von Felbert V, Basset-Seguin N, Dreno B, Girard C, Redondo P, Serra-Guillen C, Synnerstad I, Tarstedt M, Tsianakas A, Venema AW, Kelleners-Smeets N, Adamski H, Perez-Garcia B, Gerritsen MJ, Leclerc S, Kerrouche N, Szeimies RM. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2342-8.

  83. Lee SY, You CE, Park MY. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV. Lasers Surg Med. 2007 Feb;39(2):180-8.

  84. Li Q, Jiao B, Zhou F, Tan Q, Ma Y, Luo L, Zhai J, Luan Q, Li C, Wang G, Gao T. Comparative study of photodynamic therapy with 5%, 10% and 20% aminolevulinic acid in the treatment of generalized recalcitrant facial verruca plana: a randomized clinical trial. J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1821-6.

  85. Ma J, Meng N, Xu X, Zhou F, Qu Y. System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy. Acta Ophthalmol. 2014 Dec;92(8):e594-601. [PDF]

  86. Miguel-Gomez L, Vano-Galvan S, Perez-Garcia B, Carrillo-Gijon R, Jaen-Olasolo P. Treatment of folliculitis decalvans with photodynamic therapy: results in 10 patients. J Am Acad Dermatol 2015; 72: 1085–1087.

  87. Megna M, Fabbrocini G, Marasca C, Monfrecola G. Photodynamic Therapy and Skin Appendage Disorders: A Review. Skin Appendage Disord. 2017 Jan;2(3-4):166-176. [PDF]

  88. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, Haimovici R, Gragoudas ES. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 1995 Jun;113(6):810-8.

  89. Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep;117(9):1161-73.

  90. Morrison SA, Hill SL, Rogers GS, Graham RA. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer. J Surg Res. 2014 Dec;192(2):235-41.

  91. Morton C, Szeimies RM, Sidoroff A, Wennberg AM, Basset-Seguin N, Calzavara-Pinton P, Gilaberte Y, Hofbauer G, Hunger R, Karrer S, Lehmann P, Piaserico S, Ulrich C, Braathen L, European Dermatology Forum European Dermatology Forum Guidelines on topical photodynamic therapy. Eur J Dermatol. 2015;25:296–311.

  92. Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013 May;27(5):536-44.

  93. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol. 2001 Mar;137(3):319-24

  94. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol. 2000 Oct;143(4):767-72.

  95. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996 Nov;135(5):766-71.

  96. Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T, Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J Neurosurg. 2013 Oct;119(4):845-52.

  97. Newman DK. Photodynamic therapy: current role in the treatment of chorioretinal conditions. Eye (Lond). 2016 Feb;30(2):202-10. [PDF]

  98. Nicklas C, Rubio R, Cárdenas C, Hasson A. Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial. Photodermatol Photoimmunol Photomed. 2018 Jul 11. doi: 10.1111/phpp.12413. [Epub ahead of print]

  99. O'Connell KA, Okhovat JP, Zeitouni NC. Photodynamic Therapy for Bowen's Disease (Squamous Cell Carcinoma in situ) Current Review and Update. Photodiagnosis Photodyn Ther. 2018 Sep 18. pii: S1572-1000(18)30217-5. doi: 10.1016/j.pdpdt.2018.09.009. [Epub ahead of print]

  100. Ozog David M, Rkein Ali M, Fabi Sabrina G, Gold Michael H, Goldman Mitchel P., Lowe Nicholas J, Martin George M, Munavalli Girish S. Photodynamic Therapy: A Clinical Consensus Guide. American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. 2016. p.804-827. [PDF]

  101. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, Yamauchi PS. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003 Feb;48(2):227-32.

  102. Pinel S, Thomas N, Boura C, Barberi-Heyob M. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment. Adv Drug Deliv Rev. 2018 Nov 7. pii: S0169-409X(18)30281-3. doi: 10.1016/j.addr.2018.10.013. [Epub ahead of print] [PDF]

  103. Pourhajibagher M, Kazemian H, Chiniforush N, Hosseini N, Pourakbari B, Azizollahi A, Rezaei F, Bahador A. Exploring different photosensitizers to optimize elimination of planktonic and biofilm forms of Enterococcus faecalis from infected root canal during antimicrobial photodynamic therapy. Photodiagnosis Photodyn Ther. 2018 Sep 29. pii: S1572-1000(18)30242-4. doi: 10.1016/j.pdpdt.2018.09.014. [Epub ahead of print]

  104. Qian G, Wang S, Deng D, Yang G. Is the step-up therapy of topical 5-aminolevulinic acid photodynamic therapy effective and safe for the patients with recalcitrant facial flat wart? Dermatol Ther. 2014 Mar-Apr;27(2):83-8.

  105. Raab O. Über die Wirkung fluoreszierender Stoffe auf Infusorien. Z Biol. 1900;39:524–546.

  106. Regillo CD. Update on photodynamic therapy. Curr Opin Ophthalmol. 2000 Jun;11(3):166-70.

  107. Rkein Ali M, MD, Ozog David M. Photodynamic Therapy. Department of Dermatology. Dermatol Clin. 2014;32:415–425. [PDF]

  108. Roozeboom MH, Arits AH, Nelemans PJ, Kelleners-Smeets NW. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol. 2012 Oct;167(4):733-56.

  109. Rosenblatt BJ, Shah GK, Blinder K. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization. Retina. 2005 Jan;25(1):33-7.

  110. Sandberg C, Stenquist B, Rosdahl I, Ros AM, Synnerstad I, Karlsson M, Gudmundson F, Ericson MB, Larkö O, Wennberg AM. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol. 2006;86(5):404-8. [PDF]

  111. Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep;117(9):1177-87.

  112. Schwartz JA, Price RE, Gill-Sharp KL, Sang KL, Khorchani J, Goodwin BS, Payne JD. Selective nanoparticle-directed ablation of the canine prostate. Lasers Surg Med. 2011 Mar;43(3):213-20

  113. Sculean A, Aoki A, Romanos G, Schwarz F, Miron RJ, Cosgarea R. Is Photodynamic Therapy an Effective Treatment for Periodontal and Peri-Implant Infections? Dent Clin North Am. 2015 Oct;59(4):831-58.

  114. Sgolastra F, Petrucci A, Severino M, Graziani F, Gatto R, Monaco A. Adjunctive photodynamic therapy to non-surgical treatment of chronic periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2013 May;40(5):514-26.

  115. Shin JY, Woo SJ, Yu HG, Park KH. Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy. Retina. 2011 Jan;31(1):119-26.

  116. Silva RM, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Gregório T, Cachulo ML, Pires IA, Cunha-Vaz JG, Murta JN. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study. Retina. 2013 Feb;33(2):309-15.

  117. Singh AD, Kaiser PK, Sears JE, Gupta M, Rundle PA, Rennie IG. Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol. 2004 Nov;88(11):1414-8.

  118. Sivaramakrishnan G, Sridharan K. Photodynamic therapy for the treatment of peri-implant diseases: A network meta-analysis of randomized controlled trials. Photodiagnosis Photodyn Ther. 2018 Mar;21:1-9.

  119. Sorbellini E, Rucco M, Rinaldi F. Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update. Lasers Med Sci. 2018 Jul 14. [PDF]

  120. Stepp H. ALA for stereotactic interstitial PDT of malignant glioma. In: Programof the 2nd International ALA and porphyrin symposium (IAPS2) Nov 15-16, 2014, Tokio, Japan.

  121. Stevenson ML, Karen JK, Hale EK. Laser-Assisted Photodynamic Therapy: Two Novel Protocols for Enhanced Treatment Results. J Drugs Dermatol. 2017 Apr 1;16(4):329-331.

  122. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96. [PDF]

  123. Stylli SS, Kaye AH. Photodynamic therapy of cerebral glioma - a review. Part II - clinical studies. J Clin Neurosci. 2006 Aug;13(7):709-17.

  124. Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Frambach Y, de Berker D, Dummer R, Kerrouche N, Villemagne H; Excilight Study Group. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol. 2008 Nov;22(11):1302-11.

  125. Taber SW, Fingar VH, Wieman TJ. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J Surg Oncol. 1998 Aug;68(4):209-14.

  126. Tennert C, Feldmann K, Haamann E, Al-Ahmad A, Follo M, Wrbas KT, Hellwig E, Altenburger MJ. Effect of photodynamic therapy (PDT) on Enterococcus faecalis biofilm in experimental primary and secondary endodontic infections. BMC Oral Health. 2014 Nov 4;14:132. [PDF]

  127. Terra Garcia M, Correia Pereira AH, Jorge AOC, Strixino JF, Junqueira JC. Photodynamic Therapy mediated by chlorin-type photosensitizers against Streptococcus mutans biofilms. Photodiagnosis Photodyn Ther. 2018 Aug 26. pii: S1572-1000(18)30121-2. doi: 10.1016/j.pdpdt.2018.08.012. [Epub ahead of print]

  128. Tomás-Velázquez A, Redondo P. Switching From Conventional Photodynamic Therapy to Daylight Photodynamic Therapy For Actinic Keratoses: Systematic Review and Meta-analysis. Actas Dermosifiliogr. 2017 May;108(4):282-292.

  129. Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol. 2006 Dec;155(6):1262-9.

  130. Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina. 2005 Feb-Mar;25(2):119-34.

  131. Von Tappeiner H, Jesionek A. Therapeutische Versuche mit fluoreszierenden Stoffen. Muench Med Wochenschr. 1903;47:2042–2044.

  132. Wen X, Li Y, Hamblin MR. Photodynamic therapy in dermatology beyond non-melanoma cancer: An update. Photodiagnosis Photodyn Ther. 2017 Sep;19:140-152. [PDF]

  133. Yang MY, Chang KC, Chen LY, Hu A. Low-dose blue light irradiation enhances the antimicrobial activities of curcumin against Propionibacterium acnes. J Photochem Photobiol B. 2018 Sep 26;189:21-28.

  134. Yung A, Stables GI, Fernandez C, Williams J, Bojar RA, Goulden V. Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream. Clin Exp Dermatol. 2007 Nov;32(6):716-21.